Clinical Trials Logo
  1. Home
  2. Post Partum Hemorrhage
  3. NCT03449420
  4. Details
NCT03449420 Clinical Trial

Predictability of Thromboelastography Parameters in Severe Post Partum Hemorrhage

Post Partum Hemorrhage Clinical Trial

Official title:
Predictability of Thromboelastography Parameters in Severe Post Partum Hemorrhage : a Retrospective Study

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03449420
Other study ID # ArmandTrousseau
Secondary ID
Status Completed
Phase N/A
First received March 30, 2017
Last updated February 27, 2018
Start date January 2012
Est. completion date July 2015

Study information
Verified date February 2018
Source Hôpital Armand Trousseau
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of the study is to determine if thromboelastography parameters can be predictive of severe post partum hemorrhage.

Recruitment information / eligibility
Status Completed
Enrollment 100
Est. completion date July 2015
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Women presenting with a post partum hemorrhage

- needing sulprostone infusion

- during third trimester of pregnancy

Exclusion Criteria:

- known coagulation disorders

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• thromboelastography
TEG5000® : Kaolin and Functional Fibrinogen tests on native blood sample

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Hôpital Armand Trousseau

Outcome
Type Measure Description Time frame Safety issue
Primary Calculated blood loss Calculated blood loss at 24 hours after delivery (Sum of the volume of blood transfused and the volume of blood loss calculated by the decrease in hematocrit.) during the 24 hours after delivery
See also
  Status Clinical Trial Phase
Completed NCT03680339 - The Effect of Preoperative and Post Operative Misoprostol Administration on Intraoperative Blood Loss and Postpartum Hemorrhage in CS Phase 4
Completed NCT03693599 - Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean Phase 4
Completed NCT03707132 - Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta
Recruiting NCT02306733 - Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally Phase 3
Completed NCT01866241 - Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage Phase 3
Not yet recruiting NCT01236482 - Oxytocin in Cesarean Delivery Phase 4
Completed NCT03784794 - Patient Blood Management for Massive Obstetric Hemorrhage N/A
Enrolling by invitation NCT06255496 - QStat Cartridge in Obstetric Patients
Recruiting NCT04401839 - Amr Maneuver for Prevention of Postpartum Hemorrhage N/A
Recruiting NCT06219538 - DAISY Uterine Drain Device Evaluation N/A
Not yet recruiting NCT06333340 - Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery N/A
Completed NCT01863706 - Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage Phase 1
Terminated NCT04277962 - Estimating Blood Loss Using TritonTM in Vaginal Deliveries: A Validation Trial N/A
Completed NCT04723979 - NovoSeven® in Severe Postpartum Haemorrhage - Experiences From UK, DK, FR, NL
Completed NCT03570723 - Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa N/A
Completed NCT03117647 - Mansoura-VV Uterine Compression Suture for Primary Atonic Postpartum Hemorrhage N/A
Active, not recruiting NCT03069859 - Use of TXA to Prevent Postpartum Hemorrhage Phase 2
Not yet recruiting NCT03891082 - A Comparative Study Between Bakri Balloon and B Lynch Suture Used to Control Primary Postpartum Hemorrhage After Cesarean Section N/A
Not yet recruiting NCT03463070 - Misoprostol Before and After Cesarean Section Phase 3
Recruiting NCT05532215 - Sublingual Misoprostol in Reduction of Caesarean Blood Loss N/A